苯甲酰基次溴酸盐 | 6540-24-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 苯甲酰基次溴酸盐
• 英文名称: benzoyl hypobromite
• 英文别名: Benzoylhypobromit；Bromine benzoate；bromo benzoate
• CAS: 6540-24-5
• 化学式: C₇H₅BrO₂
• 分子量: 201.019
• InChiKey: FBCNRCVXBGRPQU-UHFFFAOYSA-N

物化性质

• 沸点：
  228.1±23.0 °C(Predicted)
• 密度：
  1.621±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  Alpha-甲基苯乙烯 、 苯甲酰基次溴酸盐 生成 1-(4-tolyl)vinyl benzoate
  参考文献：
  名称：

  Edwards; Hodges, Journal of the Chemical Society, 1954, p. 761

  摘要：

  DOI：
• 作为产物：
  描述：

  silver benzoate 在 四氯化碳 、 溴 作用下， 生成 苯甲酰基次溴酸盐
  参考文献：
  名称：

  Bockemueller; Hoffmann, Justus Liebigs Annalen der Chemie, 1935, vol. 519, p. 165,191

  摘要：

  DOI：

文献信息

• Alpha-helical mimetics
  申请人：Lessene Guillaume Laurent

  公开号：US20080153802A1

  公开（公告）日：2008-06-26

  Benzoyl urea derivatives that are alpha helical peptides mimetics that mimic BH3-only proteins, compositions containing them, their conjugation to cell-targeting-moieties, and their use in the regulation of cell death are disclosed. The benzoyl urea derivatives are capable of binding to and neutralizing pro-survival Bcl-2 proteins. Use of benzoyl urea derivatives in the treatment and/or prophylaxis of diseases or conditions associated with deregulation of cell death are also described.

  公开了模拟α螺旋肽的苯甲酰脲衍生物，这些衍生物模拟BH3-仅蛋白，含有它们的组合物，它们与细胞靶向基团的结合，以及它们在调节细胞死亡中的用途。苯甲酰脲衍生物能够结合并中和促生存的Bcl-2蛋白。还描述了在治疗和/或预防与细胞死亡失调相关的疾病或症状中使用苯甲酰脲衍生物。
• [EN] LASSO STRUCTURES AND THEIR SYNTHESIS<br/>[FR] STRUCTURES DE TYPE LASSO ET LEUR SYNTHÈSE
  申请人：CHROMACON AG

  公开号：WO2018091339A1

  公开（公告）日：2018-05-24

  Method for the synthesis of a molecular lasso structure consisting of a cyclic moiety and of a linear moiety, wherein the linear moiety is covalently attached to the cyclic moiety and with its free end is partially threaded through the orifice formed by the cyclic moiety, including the following steps, preferably in given order: ) provision of a cyclic moiety and of a first linear structural element and establishing conditions in which at least a fraction of the first linear structural element is threaded through the orifice of the cyclic moiety; 2) covalently attaching a stopper element preventing de-threading of the first linear structural element to one terminal end of the first linear structural element; 3) separating unthreaded cyclic moieties and first linear structural elements from threaded molecular assemblies, in which threaded molecular assemblies the first linear structural element with said stopper element is threaded through the cyclic moiety, by chemical and/or physical separation and using essentially only the threaded molecular assemblies for further reaction; 4) reacting the threaded molecular assemblies with a bifunctional second linear structural element so that the second linear structural element is covalently attached to the first linear structural element at or close to its end opposite to the end where the stopper is attached, and so that the second linear structural element is covalently attached to the cyclic moiety.

  合成分子套索结构的方法，包括一个环状部分和一个线性部分，其中线性部分与环状部分共价连接，并且其自由端部分部分穿过环状部分形成的孔，包括以下步骤，最好按照给定的顺序进行：1）提供一个环状部分和一个第一线性结构元素，并建立条件，使第一线性结构元素的至少一部分穿过环状部分的孔；2）将阻止解开第一线性结构元素的阻塞元素共价连接到第一线性结构元素的一个末端；3）通过化学和/或物理分离，将未穿过的环状部分和第一线性结构元素与穿过的分子组装体分离开来，并且仅使用穿过的分子组装体进行进一步反应；4）将穿过的分子组装体与双功能第二线性结构元素反应，使第二线性结构元素共价连接到第一线性结构元素的末端或接近末端，其中阻塞元素连接的另一端，并且使第二线性结构元素共价连接到环状部分。
• [EN] ALPHA-HELICAL MIMETICS<br/>[FR] MIMÉTIQUES D'HÉLICE ALPHA
  申请人：EARCH THE WALTER AND ELIZA HAL

  公开号：WO2006002474A1

  公开（公告）日：2006-01-12

  Benzoyl urea derivatives that are alpha helical peptide mimetics that mimic BH3-only proteins, compositions containing them, their conjugation to cell-targeting moieties, and their use in the regulation of cell death are disclosed. The benzoyl urea derivatives are capable of binding to and neutralising pro-survival Bcl-2 proteins. Use of the benzoyl urea derivatives in the treatment and/or prophylaxis of diseases or conditions associated with deregulation of cell death are also disclosed.

  本文揭示了α螺旋肽类似物的苯甲酰脲衍生物，这些类似物模拟BH3-only蛋白质，包含它们的组合物，它们与细胞靶向基团的结合，以及它们在调控细胞死亡中的用途。苯甲酰脲衍生物能够结合并中和促生存的Bcl-2蛋白。还揭示了苯甲酰脲衍生物在治疗和/或预防与细胞死亡失调相关的疾病或症状中的用途。
• [EN] NEW HETEROCYCLIC COMPOUNDS<br/>[FR] NOUVEAUX COMPOSÉS HÉTÉROCYCLIQUES
  申请人：HOFFMANN LA ROCHE

  公开号：WO2021005034A1

  公开（公告）日：2021-01-14

  The invention provides new heterocyclic compounds having the general formula (I) wherein R1, R2, X, and Y are as defined herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.

  该发明提供了具有一般式（I）的新杂环化合物，其中R1、R2、X和Y如本文所定义，包括这些化合物的组合物，制造这些化合物的过程以及使用这些化合物的方法。
• [EN] AMINE CO-INITIATOR MIXTURE<br/>[FR] MÉLANGE CO-INITIATEUR À BASE D'AMINE
  申请人：LAMBSON LTD

  公开号：WO2021074363A1

  公开（公告）日：2021-04-22

  The invention relates to a co-initiator comprising the aminobenzoate derivative according to Formula (I) and at least one ancillary amine, wherein the reactivity and solubility of said co-imitator in UV-curable resins is sufficiently high that the co-initiator can be used in UV radiation curing processes. Formula (I) wherein R1 and R2 independently represent methyl or ethyl groups; and j, k, l and m are independently 0 to 20.

  这项发明涉及一种共同引发剂，其包括按照式（I）中的氨基苯甲酸酯衍生物和至少一种辅助胺，其中所述共同引发剂在UV固化树脂中的反应性和溶解性足够高，以至于该共同引发剂可以用于UV辐射固化工艺中。式（I）中，R1和R2分别代表甲基或乙基基团；j、k、l和m独立地为0至20。